Company intelligence / Profile preview

Brevan Howard

Ownership: Private
Employees: ~430
Development stage: Other

Overview

Brevan Howard is a leading global alternative investment management platform specializing in global macro and digital assets. It is one of the world’s largest macro hedge funds with a history of strong performance during periods of market volatility. The firm manages approximately $40 billion in assets as of 2025 and operates multiple funds across various strategies but does not develop therapeutics or health-related products[1][2][3][9].

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships; partnerships are primarily within finance and asset management.

Beyond the preview

Go deeper on Brevan Howard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brevan Howard.

Explore the full profile